Page results
-
The National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH NHS Foundation Trust, has been reaccredited under the prestigious Royal College of Anaesthetists (RCoA) Anaesthesia Clinical Services Accreditation (ACSA) demonstrating the hospital anaesthetists’ commitment to patient safety and excellence of care.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
Alison Clements, head of operations, patient flow and EPRR, has received a medal in recognition of her work to support NHS preparations for the Coronation of Charles III and Camilla last May.
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Dr Alegre Abarrategui is a consultant in diagnostic neuropathology offering diagnostic services across neuropathology subspecialties, especially surgical neuropathology, neuromuscular neuropathology, and neurodegeneration.
File results
-
FOI/2024/0482 - Medical device/ enterprise application Integration/ data warehouse systems
-
FOI/2024/0368 - Treatment in renal cell carcinoma
-
FOI/2023/0418 - GIDS service patient referrals and treatment
-
FOI/2022/0655 - GIDS patients who have been prescribed GnRH analogues
-
FOI/2024/0480 - Freedom of Information (FOI) requests 2020/21-2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0254 - Urothelial and endometrial cancer treatments
-
FOI/2024/0246 - Gastric and gastro-oesophageal/ non-small cell lung/ renal cell carcinoma cancer treatments